Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches

Journal of Aging Research
Martin C Nwadiugwu

Abstract

Frail older people have an inherent risk of polypharmacy due to the need to treat multiple comorbidities, thus leading to various negative effects on their health due to the adverse actions from the drugs. This issue was discussed from a person-centered perspective, highlighting the category of frail older adults who are at a higher risk. Appropriate medication reconciliation in this population with useful prescribing tools (Beers and START/STOPP criteria) to minimize polypharmacy and to provide alternative prescriptive intervention could go alongside primary care to reduce the extent of frailty and polypharmacy. Reducing delayed referrals and extended hospitalization with electronic health record systems and using the signs of frailty from the Electronic Frailty Index (EFI) to predict polypharmacy for frail older persons are preventative approaches that proactively respond to frailty associated with the risk of polypharmacy.

References

Sep 1, 1996·The American Journal of Emergency Medicine·R M GoldbergS Wong
Oct 18, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J H FlahertyJ E Morley
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Sep 11, 2002·Patient Education and Counseling·Nicola Mead, Peter Bower
Jun 14, 2003·TheScientificWorldJournal·A B MitnitskiK Rockwood
Dec 18, 2003·British Journal of Clinical Pharmacology·A A Mangoni, S H D Jackson
Mar 19, 2004·Journal of Clinical Nursing·Brendan McCormack
Mar 19, 2004·Journal of Clinical Nursing·Mike R NolanJanet Nolan
Apr 12, 2005·Journal of the American Academy of Nurse Practitioners·Maryann M Fulton, Elizabeth Riley Allen
Feb 3, 2007·Postgraduate Medical Journal·Frank Lally, Peter Crome
May 12, 2007·Journal of the American Geriatrics Society·Sharon K InouyeGeorge A Kuchel
Dec 7, 2007·Annals of Internal Medicine·Daniel S BudnitzChesley L Richards
Jan 9, 2008·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarJoseph T Hanlon
Jan 6, 2009·Wiener klinische Wochenschrift·Jochen SchulerMax Pichler
Mar 11, 2009·Annals of Family Medicine·Kurt C Stange
Jun 13, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Janet Brandling, William House
Jan 12, 2011·European Journal of Clinical Pharmacology·Alessandro NobiliUNKNOWN SIMI Investigators
Jan 6, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Graziano OnderUNKNOWN SHELTER Project
Feb 1, 2012·Archives of Physical Medicine and Rehabilitation·Chih-Hsuan ChouYing-Tai Wu
Mar 2, 2012·The New England Journal of Medicine·Michael J Barry, Susan Edgman-Levitan
Mar 14, 2012·Annals of Family Medicine·Martin FortinHeather Maddocks
Apr 17, 2012·Clinics in Geriatric Medicine·Bhavik M Shah, Emily R Hajjar
Jun 15, 2013·Journal of the American Medical Directors Association·John E MorleyJeremy Walston
Jul 19, 2013·Biogerontology·Arnold MitnitskiKenneth Rockwood
Oct 1, 2013·Expert Opinion on Drug Safety·Robert L MaherEmily R Hajjar
Jun 11, 2014·PloS One·Hong-Ah KimByung-Joo Park
Jul 16, 2015·Age and Ageing·Jennifer K HarrisonJohn Young
Oct 9, 2015·Journal of the American Geriatrics Society·UNKNOWN By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel
Nov 12, 2015·Archives of public health = Archives belges de santé publique·Denise WalckiersJean Tafforeau
Feb 3, 2016·Therapeutic Advances in Drug Safety·Amanda Hanora Lavan, Paul Gallagher
Jul 13, 2016·The Canadian Journal of Cardiology·Kenneth Rockwood
Apr 12, 2017·Journal of the American Medical Directors Association·Nicola VeroneseStefania Maggi
Oct 5, 2017·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Bryon A TompkinsJoshua M Hare
Feb 3, 2018·Aging and Disease·Supakanya WongrakpanichJanani Rangaswami
Oct 13, 2018·Archives of Physical Medicine and Rehabilitation·Aparna ArjunanRuth E Hubbard
Nov 14, 2018·BMC Geriatrics·Donata KurpasMaria Magdalena Bujnowska-Fedak
Nov 15, 2018·JMIR Medical Education·Yacob HabboushSary Beidas
Dec 1, 2018·Frontiers in Nutrition·Ivonne Hernandez SchulmanJoshua M Hare

❮ Previous
Next ❯

Citations

Apr 6, 2021·Current HIV/AIDS Reports·Kristine M Erlandson, Damani A Piggott
May 1, 2021·Journal of Clinical Medicine·Martin C NwadiugwuDoug Russell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.